Recent Cancer Drugs Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 28
- Publication type:
- Article
Works matching IS 21641153 AND DT 2014 AND VI 4 AND IP 3
Results: 8
1
2
Increased Incidence of Recurrent Venous Thromboembolism in Patients with Cancer Receiving Bevacizumab.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 18
- By:
- Publication type:
- Article
3
Improving Patient Care and Medication Safety: Standardizing Antiemetic Agents in Chemotherapy Order Sets in a Large Healthcare System.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 12
- By:
- Publication type:
- Article
4
Ibrutinib Outperforms Ofatumumab, Extends Survival in Patients with CLL.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 9
- By:
- Publication type:
- Article
5
Enzalutamide Improves Outcomes in Metastatic Prostate Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 8
- By:
- Publication type:
- Article
6
Chemotherapy-Induced Peripheral Neuropathy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 4
- Publication type:
- Article
7
Cancer Therapy: Adverse Event Prevention and Management Education for All Pharmacists.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 1
- Publication type:
- Article
8
Panitumumab and Cetuximab Show Comparable Survival Benefit in Patients with Metastatic Colorectal Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 3, p. 10
- By:
- Publication type:
- Article